Wegovy

Semaglutide weekly injection

0.25 mg

0.5 mg

1 mg

1.7 mg

2.4 mg

Wegovy® (semaglutide 2.4 mg) is a once-weekly injection specifically approved for weight management in adults with obesity or overweight with related health conditions. It works by mimicking a natural hormone (GLP-1) that reduces hunger, increases fullness, and supports lasting weight loss. At Metabolite Clinic, Wegovy is offered as part of a comprehensive, medically supervised obesity treatment plan.

Weight Loss with Wegovy

Wegovy has been shown in clinical trials to help patients lose an average of 15% of their body weight, with some individuals losing even more.

When combined with nutritional guidance and lifestyle support, Wegovy can be a powerful tool for achieving long-term weight loss and improved metabolic health.